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Purpose: Prominin is a family of pentaspan transmembrane glycoproteins. They are expressed in various types of cells,
including many stem/progenitor cells. Prominin-1 plays an important role in generating and maintaining the structure of
the photoreceptors. In this study, we identified three prominin homologs in Xenopus laevis, a model animal widely used
in vision research, and characterized their messenger RNA (mRNA) expression in selected tissues of this frog.
Methods: Reverse-transcription PCR (RT–PCR) and rapid amplification of cDNA ends (RACE) were used to isolate
cDNAs of prominin homologs. Semiquantitative RT–PCR was used to measure the relative expression levels of mRNAs
of the three prominin homologs in four X. laevis tissues, specifically those of the retina, brain, testis, and kidney. Sequences
of prominin homologs were analyzed with bioinformatic software.
Results: We isolated cDNAs of three prominin homologs from X. laevis tissues and compared their sequences with
previously described prominin-1, 2, and 3 sequences from other species using phylogenetic analysis. Two of these
homologs are likely to be the X. laevis orthologs of mammalian prominin-1 and 2, respectively, while the third homolog
is likely to be the X. laevis ortholog of prominin-3, which was only found in nonmammalian vertebrates and the platypus.
We identified alternatively spliced exons in mRNAs of all three prominin homologs. Similar to mammalian prominin-1,
we found that exons 26b, 27, and 28a of the X. laevis prominin-1 gene are alternatively spliced, and that the splice isoforms
of mRNA show tissue-specific expression profiles. We found that prominin-1 was the most abundant homolog expressed
in the retina, brain, and testis, while prominin-3 was the most abundant homolog in the kidney. The expression level of
prominin-2 was the lowest of the three prominin homologs in all four examined tissues of this frog.
Conclusions: Our results suggest that the mRNAs of prominin homologs are expressed in many tissues of X. laevis, but
differ in their expression levels and mRNA splicing. Prominin-1 is the most abundant of the three prominin homologs
expressed in the frog retina.
The prominins are a family of pentaspan transmembrane
glycoproteins  [1-5].  The  first  member,  identified  as
prominin-1,  was  originally  cloned  from  murine  kidney
epithelial  cells  [6].  It  was  later  characterized  as  an
immunological  determinant  of  hematopoietic  and
neuroepithelial  stem/progenitor  cells  [6-8],  referred  to  as
CD133  or  AC133  [2,7].  Prominin-1  is  also  expressed  in
embryonic stem cells [9], cancer cells [10-14], some epithelial
cells [15-17], glial cells [18], and rod photoreceptors [19,20].
Prominin-1  is  specifically  associated  with  membrane
protrusions such as microvilli, filopodia, and lamellipodia
[17,21]. Maw et al. [19] reported that a frameshift mutation
(PROML11878, now designated as c.1841delG) in prominin-1
that results in the premature termination of translation causes
autosomal recessive retinal degeneration in a consanguineous
Indian  pedigree.  Another  mutation,  R373C,  of  human
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prominin-1  was  reported  to  cause  autosomal  dominant
macular degeneration in patients [22,23]. Permanyer et al.
identified a third mutation, c.869delG, of human prominin-1
that  causes  autosomal  recessive  retinitis  pigmentosa  [24].
Zacchigna et al. found that knockout of prominin-1 in mice
causes  slow  retinal  degeneration  [20].  The  specific
localization of prominin-1 in murine rod photoreceptors and
the pathological effect caused by its mutations in humans and
mice suggest that it may be involved in the generation or
maintenance of photoreceptor outer segment structure.
A second member of the prominin family, prominin-2,
shares many features with prominin-1, including a predicted
pentatransmembrane  topology  [3],  preferential  subcellular
localization  to  membrane  protrusions  [25],  binding  to
cholesterol, and association with vesicles released into the
body fluids [16,25-27]. However, the expression profile of
prominin-2  is  different  from  that  of  prominin-1  in  many
tissues [3,28,29], and prominin-2 is not detected in the mouse
eye [3].
The prominin-1 gene is alternatively spliced in human
and  mouse  tissues,  producing  multiple  splice  isoforms  of
mRNA  [2,18,30-32].  Kemper  et  al.  showed  that  the
expression of these splice isoforms is regulated in mouse
tissues, based on the fact that these splice isoforms differ in
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1381their expression profiles or levels in analyzed tissues [30]. A
region that encodes the C-terminus of the human and mouse
prominin-1 is extensively spliced [2,31,32]. The significance
of the alternative splicing of prominin-1, especially at the C-
terminus, is unknown. PDZ (Postsynaptic density protein,
PSD-95;  Discs  large  tumor  suppressor,  DlgA;  Zonula
occludens-1  protein,  ZO-1)-binding  motifs  have  been
identified in certain splice isoforms of human and mouse
prominin-1 [31]. It was postulated that these splice isoforms
interact with different partners and therefore participate in
different cellular functions [31-33].
Our goal is to study the function of prominin homologs
in the retina of X. laevis, in which photoreceptor outer segment
membrane synthesis and structure has been investigated by
retinal  cell  biologists  for  decades  [34,35],  and  for  which
genetic manipulation methods are available [36,37]. Here, we
present the results of the isolation of cDNAs of three prominin
homologs in X. laevis, comparisons with prominin homologs
from other species by phylogenetic analysis, characterization
of alternative splicing of prominin-1, and analysis of mRNA
expression  levels  of  three  prominin  homologs  by
semiquantitative RT–PCR.
METHODS
Animals: Adult X. laevis and X. tropicalis were purchased
from Xenopus Express, Brooksville, FL. The animals were
kept in an environment of artificially controlled 12 h:12 h
light-dark  cycle  and  constant  temperature  of  18  °C.  All
experiments were conducted in accordance with the Animal
Care and Use Committee of the University of Connecticut
Health  Center  and  the  ARVO  Statement  for  the  Use  of
Animals in Ophthalmic and Vision Research.
Cloning  of  Xenopus  laevis  prominin-1  cDNA:  A  protein
versus translated nucleotide BLAST search was performed
against the Sanger Institute X. laevis expressed sequence tag
(EST)  database,  using  the  protein  sequence  of  human
prominin-1 (GenBank accession number: NP_006008) as a
query. Nested reverse-transcription (RT)-PCR was performed
to isolate a partial cDNA from an X. laevis (adult) retinal
cDNA library (a gift from Dr. Joseph C. Besharse, Medical
College of Wisconsin, WI) [38]. Full-length cDNAs were
subsequently  isolated  by  performing  5′  and  3′  rapid
amplification  of  cDNA  ends  (RACE)  using  cDNA
synthesized from X. laevis retina total RNA as a template
[39].  Sequences  of  primers  used  in  nested  RT–PCR  and
RACE are provided in Table 1. The isolated cDNAs were
cloned  into  pCR  2.1  TOPO  cloning  vector  (Invitrogen,
Carlsbad,  CA)  and  sequenced  using  the  dye-termination
method [40].
Cloning of Xenopus laevis prominin-2 and 3 cDNAs: We
performed  BLAST  searches  with  sequences  of  known
prominin  homologs,  including  human  prominin-1
(NP_006008) and 2 (NP_653308), and mouse prominin-1
(NP_032961)  and  2  (NP_620089),  against  the  Ensembl
genomic  database  of  Xenopus  tropicalis  [41].  Partial
sequences resulting from this search were used to search the
X. laevis EST databases at the Sanger Institute and to design
primers to amplify prominin homologs from X. laevis by RT–
PCR and RACE, using cDNA synthesized from X. laevis
retina or testis total RNA as templates. Sequences of primers
used in RT–PCR and RACE are provided in Table 1.
Sequence  analysis  of  prominin  homologs:  Maximum
likelihood phylogeny of prominin homologs from different
species  was  generated  using  PhyML  3.0  software  [42].
TABLE 1. PRIMERS USED IN CLONING OF XLPROMININ-1, 2 AND 3 CDNAS.
Targets Sequences (5′-3′) Purpose
xlProminin-1 CGGGGTACCGTAGATCTCTTGGCATTCGCTAATG RT–PCR
  CGCGGATCCTTATGATAACCATTATTACCATTTTCCA RT–PCR
  ATTGACTGCTCCAGTGGCAC 5′RACE outer primer
  CATTAGCGAATGCCAAGAGATCTAC 5′RACE inner primer
  GTTTGGTTTGGGAGGAGCAACTGTG 3′RACE outer primer
  ATGGACACCGAAGATGTTTATGATG 3′RACE inner primer
xlProminin-2 CAGAAGGTCCAAGAGGAGTTTGC RT–PCR
  CCAGGGATTAGTTATATTGTCACACA RT–PCR
  ATTTGCATCGACTACAGCCTGC 5′RACE outer primer
  TTTTCAAGCACCAGGGGAAGGC 5′RACE inner primer
  TTGGAAAACCTGGCAACCGTGC 3′RACE outer primer
  AACTCCTTGGCTGAACTGGTCC 3′RACE inner primer
xlProminin-3 CATGTTGGCTGGAAATATCTGCATGTT RT–PCR
  TTGCCGAGATGTTGTCATCTCCAT RT–PCR
  TAGTAGCCACCAGGAGCTTAGC 5′RACE outer primer
  TCACGGCATTTACGGTGTTCAC 5′RACE inner primer
  AATTTTGCTCGCTGTGGACCAGTTGCCAGA 3′RACE outer primer
  TGCAAAGCACTACAGGAGGATGAAGACTTCT 3′RACE inner primer
Adaptor or anchor
primers for RACE
GGCCGCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG 5′RACE adaptor primer
 
GGCCGCACGCGTCGACTAGTAC 5′RACE anchor primer
 
CGACTCACTATAGGGCGATTTTTTTTTTTTTTTTT 3′RACE adaptor primer
 
CGGGGTACCGTAATACGACTCACTATAGGGCGA 3′RACE anchor primer
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1382cDNAs of prominin homologs of the human, chimpanzee,
rhesus  monkey,  rat,  mouse,  horse,  cattle,  dog,  zebrafish,
nematode, and fly were retrieved from GenBank. Prominin
homologs of X. tropicalis were cloned by methods similar to
those  used  for  X.  laevis;  cDNAs  synthesized  from  X.
tropicalis retina or testis total RNA were used as templates for
PCR and RACE. Bovine and platypus prominin homologs
were predicted from genomic sequences by BLAST search
and  by  aligning  them  with  cDNA  sequences  of  known
prominin homologs and searching for the consensus exon/
intron boundaries [43,44]. Platypus genomic sequences were
retrieved  from  Ensembl  Ornithorhynchus  anatinus  version
60.1n (OANA5) Chromosome 4. Bovine genomic sequences
were  retrieved  from  Ensembl  Bos  taurus  version  60.4i
(Btau_4.0) Chromosome 6. Other software used in sequence
analysis  included  ClustalW  for  sequence  alignments  [45],
SignalIP 3.0 for signal peptide prediction [46], NetOGlyc
3.1 for glycosylation site prediction [47], TMHMM Server,
version 2.0 for prediction of transmembrane domains [48,
49],  and  ScanProsite  software  for  identification  of  PDZ-
binding motifs [50].
RNA isolation and cDNA synthesis: RNA was extracted from
the adult X. laevis retina, brain, testis, and kidney using TRIzol
reagent  (Invitrogen)  and  used  to  synthesize  first-strand
cDNAs with SuperScript II reverse transcriptase (Invitrogen)
and oligo-dT primers (Amersham, Piscataway, NJ) according
to protocols supplied by the manufacturers.
Analysis of alternative splicing: Alternatively spliced exons
of xlProminin-1, 2, and 3 were identified by sequencing and
alignment of multiple cDNA clones. Exon/intron boundaries
were  determined  by  comparing  cDNA  sequences  with  X.
tropicalis genomic DNA sequences. The reference genomic
sequences  used  were:  X.  tropicalis  unplaced  genomic
scaffold, v4.2 XENTRscaffold_393, whole genome shotgun
sequence,  containing  the  prominin-1  gene,  GenBank
accession NW_003163719; X. tropicalis unplaced genomic
scaffold, v4.2 XENTRscaffold_30, whole genome shotgun
sequence,  containing  the  prominin-2  gene,  GenBank
accession NW_003163356; X. tropicalis unplaced genomic
scaffold, v4.2 XENTRscaffold_640 and 3098, whole genome
shotgun sequence, containing the prominin-3 gene, GenBank
accession  NW_003163966  and  NW_003166412,
respectively.  Alternative  splicing  at  the  C-terminus  of
xlProminin-1  in  the  retina,  brain,  testis,  and  kidney  was
examined by amplifying a cDNA fragment containing this
region by RT–PCR. Primers used in this analysis were: 5′-
ATA AGA ATG CGG CCG CCT GCA GAG AAC ATC CTT
TGA TAT CGA G-3′ and 5′-CGC GGA TCC CAG ATT ATT
TTC TGA AAG TCA TTT CTC C-3′. (Note that the Not I and
BamH I sites were incorporated into the primer sequences to
facilitate cloning.) The profiles and relative abundances of
differentially spliced transcripts were analyzed by comparing
the sizes and intensities of RT–PCR products resolved by
electrophoresis on a 1% agarose gel. Optical densities were
measured with ImageJ software [51] for quantification of
different splicing isoforms of xlProminin-1. Individual bands
were extracted from the gel using the GeneClean® III Kit
(Qbiogene,  Irvine,  CA),  cloned  into  the  pCR  2.1  TOPO
cloning vector (Invitrogen) and sequenced.
Semiquantitative  reverse-transcription  PCR:  Two  primer
pairs  were  designed  for  specific  amplification  of  each
prominin  homolog  (Table  2  for  sequences  of  primers).
Reverse-transcriptase PCR amplification of a fragment of β-
actin was used as a loading control to establish that an equal
amount  of  starting  materials  was  used  (Table  2).  PCR
reactions were assembled using an Advantage® 2 PCR Kit
TABLE 2. PRIMERS USED IN SEMIQUANTITATIVE REVERSE-TRANSCRIPTION (RT)-PCR OF XLPROMININ HOMOLOGS.
Targets Primer
pairs
Sequences (5′-3′) Expected MWs
xlProminin-1 1 GAAATTGGCTTTATCATTGCGGCAGTA 1939-1993a bps
    AGTAGCCAATGACTTCATCCATTAACTT  
  2 AACCTTACCAACCAGATTAGAGGATCA 1601-1655a bps
    ACCTTCCCCTCGATATCAAAGGATG  
xlProminin-2 1 CAGAAGGTCCAAGAGGAGTTTGC 1800 bps
    CCAGGGATTAGTTATATTGTCACACA  
  2 GTGCTTGAAAAGATTGTATCTTCTTTC 1370 bps
    AAGGCATTGGCTTCACTCTGTAGC  
xlProminin-3 1 GAAGTTGACTTAATAATTGGCCAAAGT 1881 or 1902b bps
    GAGAGCAATGAGAGAGACATTTCAG  
  2 CATGTTGGCTGGAAATATCTGCATGTT 1436 bps
    AACTGTCTTTCGCCAGCGTAGC  
X. laevis β-actin (as control)   GGCTATGCTCTACCACATGCCA 532 bps
    TGGAGCCACCAATCCAGACA  
        aThe expected MWs of these fragments varies with the presence or absence of the alternatively spliced exons 8a (24 bps), 11a
        (12 bps) and 19 (18 bps). The differences in sizes of these PCR products are too small to be resolved on a 1% agarose gel.
        bThe expected MWs of these fragments varies with the presence or absence of the alternatively spliced exons 24a (21 bps). The
        differences in sizes of the two PCR products are too small to be resolved on a 1% agarose gel.
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1383(Clontech, Mountain View, CA) in a final volume of 100 μl
containing 4 μl of cDNA. Aliquots (20 μl) taken at the end of
the 27th, 31st, 35th, and 39th cycles were visualized on a 1%
agarose gel by ethidium bromide staining, and digital images
were analyzed using Image J software. The total amount of
DNA in selected areas was represented with integrated optical
densities. Results obtained with two different primer pairs
were averaged and plotted.
RESULTS
Identification of three prominin homologs in Xenopus laevis:
By performing a BLAST search of the X. laevis EST database,
we retrieved a sequence (GenBank accession: BJ061435) with
62% similarity to human prominin-1. BLAST search of the
NCBI  nucleotide  database  and  the  Ensembl  X.  tropicalis
genomic database using the available sequences of prominin
homologs from different species as query sequences revealed
three different prominin homologs in X. tropicalis. These
sequences have the assigned GenBank accession numbers of
BC127277, XM_002932561, and XM_002940570. Sequence
BC127277 showed a high degree of protein sequence identity
(95%) to the above mentioned X. laevis sequence BJ061435.
However, X. laevis homologs of sequences XM_002932561
and XM_002940570 could not be retrieved from any public
cDNA or genomic database by BLAST search, perhaps due
to incomplete coverage of the X. laevis sequences by those
databases.  They  were  instead  cloned  by  RT–PCR  using
specific primer pairs based on X. tropicalis prominin homolog
sequences, employing cDNA synthesized from total RNA
isolated from X. laevis tissues as templates. Multiple clones
were obtained and sequenced. Full-length cDNA sequences
of the three X. laevis prominin homologs were obtained by
performing 5′ and 3′ RACE. Predicted protein sequences are
aligned in Figure 1.
Phylogenetic  analysis  of  prominin  homologs:  Previous
taxonomic  studies  of  prominins  have  divided  prominin
homologs into three groups. These are prominin-1 [2,31] and
prominin-2  in  mammals  [3],  and  prominin-3  in  zebrafish
[52]. Two variants of prominin-1, namely prominin-1a and
1b, were identified in zebrafish [52]. We performed protein
phylogenetic  analysis  using  the  PhyML  3.0  software  to
compare  X.  laevis  prominin  homologs  with  available
prominin sequences; the results are presented in Figure 2. The
sequences used to construct the phylogenetic tree were from
online public databases, newly cloned cDNAs, or predicted
mRNAs from genomic sequences (Methods). Since the N- and
C-termini of prominin homologs were incomplete in many of
the retrieved sequences, only the sequences from exon 4 to
exon 24 of prominin-1 and homologous sequences of other
prominins  were  used  for  the  phylogenetic  analysis.  The
analysis revealed that the first cloned prominin homolog is the
X. laevis ortholog of prominin-1, and is therefore designated
as xlProminin-1. The other two prominin-like cDNAs found
in  X.  laevis  were  named  xlProminin-2  and  xlProminin-3
according to their positions on the phylogenetic tree.
All newly cloned and predicted prominin homologs were
also named according to their positions on the phylogenetic
tree, and full sequences (including certain splice variants)
were deposited in GenBank with assigned accession numbers
(see  Table  3  and  Table  4),  including  sequences  from:  X.
tropicalis,  fugu,  platypus,  and  cattle.  We  made  new
predictions for bovine prominin-1 from genomic sequences,
because previously predicted bovine prominin-1 sequences
(XP_875477 and XP_002688513) contain obvious errors and
cannot be used for an accurate phylogenetic analysis. Our
newly predicted bovine prominin-1 was assigned with the
GenBank  accession  HQ159409.  Sequences  used  in  the
phylogenetic analysis and the alignment of these sequences
are presented in Appendix 1.
We compared the results of our phylogenetic analysis of
prominin homologs with previous findings and found that X.
laevis and X. tropicalis are the only species verified so far to
possess  all  three  prominin  orthologs.  Only  two  prominin
homologs,  prominin-1  and  2,  were  found  in  human  and
mouse.  We  conducted  BLAST  searches  of  the  NCBI
nucleotide database and the Ensembl database for prominin
homologs in more species of mammals, including the human,
chimpanzee, rhesus monkey, cattle, horse, dog, and rat. All
retrieved prominin homolog sequences from these mammals
were  better  grouped  with  prominin-1  or  2  than  with
prominin-3. A total of three prominin homologs were found
in  zebrafish  (Danio  rerio)  and  fugu  (Takifugu  rubripes).
However, these fish do not have a prominin-2 homolog; they
instead have two prominin-1 homologs, prominin-1a and 1b,
and a prominin-3 homolog [52]. Incomplete sequences of
prominin  homologs  were  retrieved  from  EST  or  genomic
databases  of  the  chicken  (Gallus  gallus)  and  platypus
(Ornithorhynchus anatinus, a primitive egg-laying mammal).
GenBank accession numbers of these sequences are given in
Table 3. They seem to group with prominin-1, 2, or 3 by
sequence alignment. However, further taxonomic studies are
needed  to  precisely  position  them  in  the  phylogeny  of
prominins. Three C. elegans prominin homologs and two D.
melanogaster prominin homologs were used in constructing
the prominin phylogeny. These sequences did not belong to
any  of  the  three  groups  of  prominins  in  our  analysis,
suggesting the possibility of other prominin homologs.
All  three  prominin  homologs  are  predicted  to  be
pentatransmembrane glycoproteins: Similar to mammalian
prominins,  hydropathy  analysis  using  TMHMM  software
predicted that all X. laevis homologs have five hydrophobic
domains,  which  likely  constitute  membrane-spanning
domains that divide the sequence into two small intracellular
loops and two large extracellular domains. However, the last
hydrophobic sequence in xlProminin-2 did not reach the set
threshold of TMHMM for prediction of a transmembrane
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1384domain  (Appendix  2).  Alignment  of  translated  protein
sequences  from  three  cloned  X.  laevis  prominin  homolog
cDNAs  reveals  that  the  most  conserved  regions  are  the
transmembrane  domains,  as  illustrated  in  Figure  1.  A
cysteine-rich region at the junction of the first transmembrane
domain and intracellular loop (M1 and I1) is conserved in
Figure  1.  Alignment  of  the  predicted
protein  sequences  of  three  X.  laevis
prominin  homologs,  showing
characteristic  features  of  prominins,
including the pentaspan transmembrane
topology,  a  conserved  cysteine  rich
domain, conserved leucine residues and
N-glycosylation  sites.  We  designated
the three X. laevis prominin homologs
as xlProminin-1, 2, and 3, respectively.
Identical  and  conserved  residues  are
indicated  by  differentially  shaded
boxes.  Predicted  transmembrane
domains  are  marked  with  M#.  The
predicted  signal  peptides  of
xlProminin-1 and 2 are boxed. No signal
peptide was predicted for xlProminin-3.
Positions of alternatively spliced exons
are  indicated  by  arrows  and  the
sequences  of  the  alternatively  spliced
exons are given. Note that the N- and C-
termini of the three X. laevis prominin
homologs are less conserved than other
regions.  Cysteine  residues  at  the
junction of M1 and the first intracellular
domain  (I1)  are  marked  with  yellow.
Conserved leucine residues of the three
xlProminin homologs are marked with
red. Conserved glycosylation sites are
marked with green.
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1385Figure 2. Phylogenic analysis of prominin homologs from several species. This phylogenetic tree was constructed to show the existence of
multiple prominin homologs in metazoan animals from fly to human and their evolutionary relationship. Three X. laevis prominin homologs,
designated as xlProminin-1, 2, and 3, are placed in branches of the consensus phylogenetic tree with prominin-1, 2, and 3 from other species.
The numbers at each node are the percentage bootstrapping values of 100 replicates. The evolutionary distance of any two sequences is
represented by the length of the branches. Sequences used in the phylogenetic analysis are excerpted from: H. sapien Prom-1 (NP_006008),
P. troglodytes Prom-1 (XP_517115), M. mulatta Prom-1 (NP_001070888), R. norvegicus Prom-1 (NP_068519), M. musculus Prom-1
(NP_032961), C. familiaris Prom-1 (XP_850831), B. taurus Prom-1 (HQ159409), E. caballus Prom-1 (XP_001498729), D. rerio  Prom-1a
(NP_001108615), T. rubripes Prom-1a (HQ159405), D. rerio Prom-1b (NP_932337), T. rubripes Prom-1b (HQ159406), O. anatinus Prom-1
(HQ159408), G. gallus Prom-1 (XP_001232165), X. laevis Prom-1 (NP_001163920), X. tropicalis Prom-1 (HQ159400), H. sapien  Prom-2
(NP_653308), P. troglodytes Prom-2 (XP_001143498), C. familiaris Prom-2 (XP_854455), B. taurus Prom-2 (XP_599188), E. caballus
Prom-2 (XP_001494215), R. norvegicus Prom-2 (AAN63818), M. musculus Prom-2 (NP_620089), X. laevis Prom-2 (NP_001163922), X.
tropicalis Prom-2 (HQ159402), X. laevis Prom-3 (NP_001163921), X. tropicalis Prom-3 (HQ159403), D. rerio Prom-3 (XP_684527), T.
rubripes Prom-3 (HQ159407), D. melanogaster Prominin (ABH07113), D. melanogaster Prominin-like protein AF127935 (NP_647770), C.
elegans protein F08B12 (NP_509907), C. elegans protein M28.8 (NP_496294), C. elegans protein M28.9 (NP_496296).
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1386xlProminin-1 and 3, but is less conserved in xlProminin-2.
Multiple leucine residues on the extracellular domains (E2
and E3) are conserved in all three xlProminin homologs. The
conserved cysteine-rich region and leucine residues were all
previously identified in mammalian prominin-1 and 2 [3,6,
53,54]. The extracellular domains of all three xlProminins
contain consensus sequences for N-linked glycosylation. In
contrast to mouse and human prominin-1, no PDZ-binding
motifs were identified in the C-terminal splice variants of
xlProminin-1,  2,  or  3  using  ScanProsite  software.  PDZ-
binding motifs were identified on the C-termini of certain
splice variants of prominin-1 in the rodent (s1, s2, s7, s8, and
s11) and human (s3, s4, s5, and s9) models, [31] and could
potentially modulate interactions of prominin-1 with other
proteins.
Three  prominin  homologs  are  differentially  expressed  in
Xenopus  laevis  tissues:  Although  prominin-1  is  broadly
expressed, the principle phenotype observed in patients is
retinal degeneration [19,20,22-24]. It was proposed that there
may be functional and spatial overlap of prominin homologs
in most tissues, such that they compensate for one another if
a loss of function mutation occurs [3]. We therefore analyzed
expression of the three xlProminin homologs in different X.
laevis tissues to assess their relative expression levels in those
tissues.  We  were  particularly  interested  in  determining
whether any prominin homolog is predominantly expressed
or absent in particular tissues among the four we studied.
We performed semiquantitative RT–PCR with mRNAs
isolated from the X. laevis retina, brain, testis, and kidney to
analyze the expression profiles of xlProminin-1, 2, and 3,
because  these  four  tissues  are  mRNA  rich  and  differ
significantly in their function and metabolism. The results are
presented  in  Figure  3.  Precautions  were  taken  to  ensure
specificity of the PCR reaction and accuracy of the analysis,
including ensuring that measurements were consistent when
using two completely different primer pairs for each prominin
homolog. We also used relatively large PCR products (>1.4
kb),  such  that  small  nonspecific  products  could  easily  be
recognized  and  disregarded.  For  the  primer  design,  we
carefully chose primers that only complement the desired
homolog.  We  found  that  mRNAs  of  three  xlProminin
homologs  were  differentially  expressed  in  these  tissues:
xlProminin-1 was the predominant form found in the retina,
brain, and testis, while xlProminin-3 was the predominant
form  found  in  the  kidney.  The  expression  level  of
xlProminin-2 was the lowest of the three prominin homologs
in all examined tissues in this frog.
Splice variants of Xenopus laevis prominin-1: A total of seven
full-length  splice  variants  (s1–s7)  of  xlProminin-1  were
cloned and sequenced, and the presence or absence of certain
alternatively spliced exons is summarized in Table 4. These
splice variants were not named following the nomenclature
for  splice  variants  of  human  and  mouse  prominin-1  [31],
because some alternative exons in xlProminin-1 do not have
corresponding exons in human and mouse, and vice versa.
TABLE 3. EVIDENCE FOR EXISTENCE OF FULL-LENGTH OR PARTIAL SEQUENCES OF PROMININ HOMOLOGS IN NON-MAMMALIAN VERTEBRATES AND PLATYPUS.
Species Prominin-1 Prominin-2 Prominin-3
Prominin-1a Prominin-1b
Zebrafish (D.rerio) NP_001108615 NP_932337 Not found XP_684527
Fugu (T. rubripes) HQ159405 HQ159406 Not found HQ159407
Frog (X. laevis) NP_001163920 NP_001163922 NP_001163921
Frog (X. tropicalis) HQ159400, HQ159401, BC127277 HQ159402 HQ159403
Chicken (G. gallus) XP_001232165 XP_425759 AF406812
Platypus (O. anatinus) HQ159408 XP_001509143 XP_001511144
TABLE 4. PRESENCE OR ABSENCE OF ALTERNATIVELY SPLICED EXONS IN FULL-LENGTH CDNAS OF THE XLPROMININ-1 AND XTPROMININ-1 SPLICE VARIANTS.
Sources Splice
variants
3a 8a 11a 19 26b 27 28a X. laevis   X. tropicalis
(xtProminin-1)
Retina s1 --- + - - - JF274976 HQ159400
s2 - JF274977  
s3 JF274978  
s4 JF274979  
s5 JF274980 HQ159401
Kidney s6 + - - +++ + FJ358518
 
s7 JF274981  
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-                +               +                 -                  -                -
+                -                +               +                 -                  -                -
-                 -                +               +                +                  -                -
-                 -                 -                -                 +                 +               +
-                 +               +               +                 -                  -                 -
(xlProminin-1)Comparison of exon organization of X. laevis, mouse, and
human prominin-1 is described in detail below. Alignment of
these  cloned  cDNAs  reveals  that  there  are  at  least  seven
alternatively spliced exons in the xlProminin-1 gene (Figure
4).  We  numbered  exons  following  the  established
nomenclature [31]. Exons 3a (“a” for “alternative”), 8a, 11a,
and 28a are newly discovered alternative exons found in X.
laevis. They were numbered based on their positions relative
to the constitutive exons. Exons 19, 26b, and 27 are alternative
exons in the human and mouse that were alternatively spliced
in  X.  laevis.  Alternatively  spliced  exons  26b  to  28a  of
xlProminin-1 reside in a region encoding the C-terminus of
the protein. Exons 3 and 28 of xlProminin-1 were always
retained, despite the fact that they appear to be alternative in
the mouse and human [2,31]. We noticed that the inclusion or
deletion of these alternatively spliced exons does not change
the downstream reading frame, except for exon 28a, within
which an in-frame stop codon resides. Inclusion of exon 28a
results in a longer but different protein sequence for the C-
terminus of xlProminin-1 relative to other isoforms.
Xenopus  laevis  prominin-2  and  3  are  also  alternatively
spliced: Multiple variants arising from alternative splicing of
all three prominin homologs were identified among mRNAs
isolated from different tissues (Figure 4). A region near the 5′
end of xlProminin-2 transcript was alternatively spliced. Exon
1 of xlProminin-2 was predicted to contain the translation
Figure  3.  Semiquantitative  reverse-
transcription  PCR  analysis  of
xlProminin-1, 2, and 3 performed on the
retina,  brain,  testis,  and  kidney.  A:
Aliquots  (20  μl)  of  the  PCR  reaction
were taken at the end of the 27th, 31st,
35th,  and  39th  cycles,  separated  and
visualized on a 1% agarose gel. Two
independent primer pairs (see Table 2)
were used to amplify each xlProminin
homolog  in  each  tissue  to  ensure  the
specificity and efficiency of the PCR
reaction. A fragment of Xenopus laevis
β-actin cDNA was also amplified from
equivalent  starting  material  of  total
RNA  to  serve  as  a  control.  The
Invitrogen 1KB PLUS DNA (Cat. No.
10787–018)  ladder  was  used  for  size
standards. B: Integrated signals in areas
occupied  by  individual  DNA  bands
were quantified and plotted to compare
the  relative  expression  level  of
xlProminin-1, 2, and 3 in four X. laevis
tissues:  the  retina,  brain,  testis,  and
kidney.  xlProminin-1,  2  and  3  are
expressed in all four tissues. Among the
three prominin homologs, prominin-1 is
predominantly expressed in the retina,
brain,  and  testis,  while  prominin-3  is
predominantly expressed in the kidney.
The expression level of prominin-2 is
the  lowest  of  the  three  prominin
homologs in all examined tissues, and is
barely detectable in the kidney.
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1388initiation site (ATG). Surprisingly, exon 1 was skipped in one
of the sequenced clones, implying an alternative start codon
in  exon  2.  This  proposed  alternative  start  codon  was
associated with a suboptimal Kozak consensus sequence (−3
CAAATGG  +4).  The  sequence  of  one  full-length
xlProminin-2  was  obtained;  this  was  assigned  GenBank
accession FJ358519. The 5′ end of xlProminin-3 transcript
and its exon 24a were found to be alternatively spliced. Two
full-length splice variants (s1 and s2) of xlProminin-3 were
obtained,  and  assigned  GenBank  accession  numbers
FJ358520  and  JF274982,  respectively.  xlProminin-3.s1
contains  an  alternatively  spliced  exon  24a,  while
xlProminin-3.s2  does  not.  Details  of  exon  organization,
alternative 5′ untranslated region (UTR) or alternative polyA
sites at 3′ UTR of xlProminin-1, 2, and 3 are provided in
Appendix 3. The functional significance of the alternatively
spliced variants is unknown.
Characterization of alternative splicing of Xenopus laevis
prominin-1  in  exons  20  to  28:  Fargeas  et  al.  previously
reported that splicing of the prominin-1 gene in mice results
in great variations in the sequences of alternative C-termini
[32].  We  therefore  examined  the  splicing  profile  of
xlProminin-1 within a region from exon 20 to 28 by RT–PCR
(Figure 5). We found that the two most abundant isoforms of
xlProminin-1 in the X. laevis retina did not contain exon 27;
their exon compositions were: (20–24)+26b-27-28a-28+ (ε in
Figure  5)  or  (20–24)+26b+27-28a-28+  (δ  in  Figure  5).
Isoforms containing exon 28a were also detected in the retina;
their exon compositions were: (20–24)+26b-27-28a+28+ (γ
in Figure 5), (20–24)+26b+27-28a+28+ (β in Figure 5) and
(20–24)+26b+27+28a+28+  (α  in  Figure  5).  However,
isoforms containing exon 28a only accounted for a very small
proportion of all xlProminin-1 in the retina (Figure 5). This
result was unlikely to be biased by preferential amplification
of  smaller  PCR  products,  since  profiling  of  xlProminin-1
alternative splicing in this region gave very different results
in the kidney, testis, and brain: Those tissues preferentially
express the isoforms with exon 28a (Figure 5).
Comparison  of  the  exon  organization  of  Xenopus  laevis,
mouse, and human prominin-1: The organization and splicing
of prominin-1 exons in the mouse and human have been well
characterized  [30-32].  To  determine  whether  the  gene
structure  is  conserved  in  xlProminin-1,  we  aligned  all
identified  exons  of  prominin-1  from  X.  laevis,  mice,  and
humans (Figure 6). Some exons found in one species were
absent in another, but these were always alternatively spliced
exons  (Figure  6).  We  also  correlated  the  positions  of  all
alternatively spliced exons of xlProminin-1 to its membrane
topology  and  found  that  all  alternatively  spliced  exons
represent sequences coding for the extracellular domains (E1,
E2, and E3) or the C-terminus of the protein, as was previously
observed in prominin-1 from mouse and human [3,30-32].
DISCUSSION
All  members  of  the  prominin  family  are  predicted  to  be
pentaspan  transmembrane  proteins  with  extracellular  N-
termini and intracellular C-termini [1,3,7,55]. They have two
large extracellular domains (around 250 amino acids each)
and two small intracellular domains (around 30 amino acids
each). The two extracellular domains are predicted to be N-
glycosylated and have conserved leucine residues. The first
intracellular domain is unusually rich in cysteine (there are 7,
4, and 8 cysteine residues in the I1 domain of xlProminin-1,
2, and 3, respectively). These features are highly conserved in
Figure  4.  Exon  organization  of
xlProminin-1,  2,  and  3.  Homologous
exons  of  xlProminin-1,  2,  and  3  are
aligned. Genes of all three xlProminins
are alternatively spliced and their exon
organization  is  evolutionarily
conserved.  Constitutive  exons  are
marked in black. Alternatively spliced
exons are marked orange. Spliced forms
identified in cDNA clones are indicated
by joining lines. Translation start sites
(ATG) are marked with green lines and
the  positions  of  translational  stop
codons  are  marked  with  white  lines.
Note the complex splicing of exons 26b,
27,  and  28a,  which  generates  several
distinct  isoforms  of  xlProminin-1.
Positions  of  primers  used  in  reverse-
transcription  (RT)-PCR  for
semiquantitative  analysis  of  mRNA
expression and for alternative splicing
are indicated on the diagram.
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1389Figure 5. Analysis of the xlProminin-1 alternatively spliced isoforms in four tissues: the retina, brain, testis, and kidney. We found that profiles
of the xlProminin-1 alternative splicing are different in these tissues. A: Products of reverse-transcription PCR (RT–PCR) from a region of
extensive alternative splicing on the xlProminin-1 gene (exon 20 to 28) were separated on a 1% agarose gel and visualized with ethidium
bromide staining. Five discrete PCR products were excised from the gel, cloned, and sequenced. Their exon compositions were determined
and each product was designated with a Greek letter (α, β, γ, δ, and ε) for identification when used in the quantitative analysis shown in panel
B. The predominant isoforms of xlProminin-1 expressed in the retina lack the alternatively spliced exons 26b, 27, and 28a, whereas the
predominant isoform of xlProminin-1 expressed in the kidney retains these exons. The predominant isoforms of xlProminin-1 expressed in
the brain and kidney retain exon 28a. Exon 27 was retained only when exon 26b was retained as well. B: Quantification of the xlProminin-1
alternatively spliced isoforms in four tissues: the retina, brain, testis, and kidney. The resolved RT–PCR products were linearly scanned and
the optical densities were plotted. Green arrows indicate peaks that represent isoforms resulting from alternative splicing. The major isoform
of xlProminin-1 expressed in the retina, ε, lacks the alternatively spliced exons 26b, 27, and 28a, whereas the major form of xlProminin-1
expressed in the kidney, α, retains all possible exons. The majority of xlProminin-1 expressed in the brain and kidney retains exon 28a.
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1390all identified prominin homologs, including xlProminin-1, 2,
and  3  (Figure  1),  suggesting  that  they  are  functionally
important.  However,  the  cysteine-rich  domain  of
xlProminin-2 is not as well conserved as that of xlProminin-1
and 3.
Only two prominin homologs, namely prominin-1 and 2,
were found in the human and mouse in previous studies [3,6,
8].  Prominins  in  other  mammals  are  less  studied,  but
consistent with the findings in the human and mouse, we did
not  find  prominin-3  homologs  in  the  chimpanzee,  rhesus
monkey, horse, cattle, dog, or rat. By contrast, three prominin
homologs were identified or their existence was inferred in
some  nonmammalian  vertebrates  (Table  3  and  Table  4),
including  fish  (D.  rerio  [52]  and  T.  rubripes),  frogs  (X.
laevis and X. tropicalis), and birds (G. gallus). However,
phylogenetic analysis revealed that zebrafish and fugu lack an
ortholog  of  prominin-2.  These  fish  instead  have  two
prominin-1  genes,  namely  prominin-1a  and  1b  [52].  In
Figure 6. Comparison of exon organization of prominin-1 gene from X. laevis, mouse, and human. It appears that the gene structure of
prominin-1 is evolutionarily conserved in these animals. Alternative splicing of the prominin-1 gene is seen in all three animals, however,
with considerable differences in the choices of alternative exons and the splicing patterns. Homologous exons of xlProminin-1 and mouse and
human prominin-1 are aligned for comparison of their exon organization. Constitutive exons are marked in black. Alternatively spliced exons
are marked in orange. Spliced forms identified in cDNA clones are indicated by jointed lines. Note that homologous exons are assigned with
the same number to maintain consistency with preexisting nomenclature [2,31]. Exons 26b and 27 are conserved and alternatively spliced in
all three species. Alternative exons 3a, 8a, 11a, and 28a of xlProminin-1 are not found in mouse or human prominin-1. Splicing of alternative
exons 4a results from using an alternative 3′ splice site in exon 4, and is only observed in mouse prominin-1 [31]. Alternative exon 19 of
xlProminin-1 is alternatively spliced in mouse prominin-1, but no evidence has been found that this exon is alternatively spliced in human
prominin-1. Alternative exon 25 of human prominin-1 is not found in prominin-1 from the mouse or X. laevis. The alternative exon 26a of
mouse prominin-1 and the alternative exons 25 and 26a of human prominin-1 are not found in xlProminin-1. Exons 3, 9, and 28 of mouse
prominin-1 are alternative, but appear to be constitutive in X. laevis. The region encompassing exons 24 to 28 of xlProminin-1 and homologous
sequences of the prominin-1 gene from the mouse and human are regions of extensive alternative splicing. Diagrams of translated proteins
are aligned with their coding sequences. Divisions of proteins by predicted transmembrane domains are marked.
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1391contrast, we determined that both X. laevis and X. tropicalis
have  all  three  prominin  homologs  that  are  orthologs  of
prominin-1,  2,  and  3  (Figure  2).  It  appears  that  the  third
homolog was lost during mammalian evolution. Interestingly,
genomic sequences encoding three prominin homologs are
retrievable from the platypus (O. anatinus;Table 3). Studies
of platypus prominin may provide clues for how prominin
homologs have evolved. It may be that prominin-1 and 2 have
extensive functional overlap, since there is shared expression
of prominin-1 and 2 in most mouse tissues except the eye
[3]. Our results showed that mRNAs of all three xlProminin
homologs are expressed in the four examined tissues of X.
laevis  at  various  levels  (Figure  3).  The  localization  and
functions of prominin homologs may overlap, and thus the
loss of one homolog through mutation may be compensated
for in most tissues by other prominins.
Several  prominin  homologs  have  been  identified  or
predicted in C. elegans (e.g., NP_509907, NP_496294, and
NP_496296)  and  D.  melanogaster  (e.g.,  NP_647770  and
ABH07113) [1,6,56,57], while no prominin homologs have
been found in bacteria, fungi, or plants, suggesting that the
prominins appeared during metazoan evolution, increased to
three genes in nonmammalian vertebrates, and subsequently
reduced to two in mammals. Since prominins are not present
in any unicellular species whose genome has been sequenced,
we postulate that prominin-like proteins are important for
intercellular  interactions,  such  as  cell-cell  adhesion,
migration,  and  communication,  or  in  developmental
processes. For example, Zelhof et al. demonstrated that in the
Drosophila retina, prominin interacts with an extracellular
matrix molecule, spacemaker, to control the apposition of
photoreceptor rhabdomeres [57]. Similar to those described
in  Bardet-Biedl  syndrome  [58],  polydactyly  phenotypes
observed in PROML11878 (now designated as c.1841delG)
patients [19] suggest a role in development: Mutations may
directly or indirectly interfere with ciliary signaling pathways
such as those mediated by smoothened [59].
Our study specifically addresses the mRNA expression
of prominin homologs in X. laevis. The processes of mRNA
and protein expression are often not well correlated. mRNAs
may be regulated independently of the encoded proteins, and
some  mRNAs  are  not  translated  at  all.  Such  genes  are
categorized  as  “pseudogenes”  [60].  In  fact,  nontranslated
mRNAs can serve important roles in regulating the expression
and degradation of other homologous mRNAs [61-64]. We
have verified that the protein encoded by the xlProminin-1
gene is detectable in X. laevis tissues by both immunoblotting
and immunohistochemistry (data not shown). To date, we
have  been  unable  to  determine  whether  proteins  of
xlProminin-2  and  3  are  synthesized  in  frog  tissues.
Nevertheless,  the  presence  of  long,  uninterrupted,
evolutionarily conserved reading frames (Figure 1) suggests
that these do not represent pseudogenes.
We  observed  alternative  splicing  of  all  prominin
homologs in X. laevis (Figure 4). Alternative splicing sites
were not found in exons coding for the two small intracellular
loops, but only in exons coding for the three extracellular
domains and the C-terminus. A region encompassing exons
26b to 28a of the X. laevis prominin-1 gene is a region of
extensive alternative splicing (Figure 5). In extreme cases,
alternative splicing of prominin-1 genes can yield proteins
with  completely  different  C-termini,  which  can  also  vary
greatly  in  length.  The  significance  of  these  isoforms  is
unknown. Alternative splicing is regarded as a mechanism to
diversify the mRNA products from a single gene, and can
confer  multifunctionality  to  gene  products  by  generating
isoforms  that  have  novel  protein  interaction  domains  or
localization  signals.  We  found  that  certain  xlProminin-1
splice  variants  are  preferred  in  certain  tissues;  splicing
variants with exon composition of 24+26b-27-28a-28+ and
24+26b+27-28a-28+  that  encode  proteins  of  shorter  C-
terminus length are the preferred isoforms in the X. laevis
retina  (Figure  5).  It  may  therefore  prove  informative  to
examine the localization of alternatively spliced forms, or to
search for novel interaction partners by techniques such as
crosslinking, coimmunoprecipitation, or two-hybrid analysis.
Tissue-specific distributions of certain isoforms could also
explain the tissue-specific phenotypes (retinal degeneration)
observed with mutations in this otherwise broadly expressed
gene  [19,20,22-24].  Comparison  of  exon  organization  of
prominin-1  in  the  human,  mouse,  and  frog  reveals  that
although  there  are  considerable  differences  in  both  the
existence  and  composition  of  certain  alternatively  spliced
exons, all three prominin-1 homologs share similar forms of
alternative splicing, especially at the region encoding for the
C-termini of the proteins (Figure 6). A recent study found that
isoforms s11 and s12 that lack exon 27 are the predominant
alternative  splicing  form  in  the  human  retina  [24].  These
findings support the use of X. laevis as a suitable model system
for investigating prominin-1 function in the retina.
Our findings of three prominin homologs in X. laevis and
characterization of their mRNA expression and alternative
splicing paves the way for future studies of the function of
these prominins in photoreceptors in this frog. There are many
advantages  of  studying  X.  laevis  photoreceptors  in
comparison  to  mammalian  photoreceptors:  The
photoreceptors of X. laevis are much larger than mammalian
photoreceptors, and are easily imaged in detail by confocal
microscopy. This frog’s retina contains nearly equal numbers
of rods and cones, allowing for comparative investigation of
both cell types. Furthermore, studies of photoreceptor outer
segment biosynthesis have been conducted in frogs because
of their large size and high rates of membrane turnover [34,
35].  Finally,  transgenic  manipulation  of  X.  laevis  is
comparatively easy and allows for the study of the transgene
effects in relatively large numbers of animals in a timely
manner [36,37].
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1392Future directions for studying the function of prominins
in photoreceptors may be focused on the turnover, transport,
subcellular  localization,  and  interacting  partners  of  these
molecules in X. laevis. Disease-causing mutations of human
prominin-1 could be introduced to xlProminin-1, if they reside
in conserved domains, and used to develop useful transgenic
X. laevis disease models. This approach has proven successful
in many studies, including investigations of the pathogenesis
of the rhodopsin P23H mutation [65-67] and T22N mutation
of rab8 [68]. None of the currently identified mutations of
prominin-1 that cause human disease are located in alternative
exons. It is unclear if any of the alternatively spliced isoforms
is  associated  with  disease  pathogenesis.  It  would  be
informative to elucidate the function of each specific splice
isoform by the specific knockdown of its mRNA with the
RNA  interference  technique  [69,70],  which  has  been
successfully applied in X. laevis [71-73].
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